Investing Profile

Andrew Levin

VC
Partner and Managing Director at RA Capital Management
Photo of Andrew Levin, Partner at RA Capital Management

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Massachusetts Institute of Technology Network
392 CONNECTIONS
Princeton University Network
245 CONNECTIONS
RA Capital Management Network
35 CONNECTIONS
RA Capital Management Network
35 CONNECTIONS
cb
23
$308.2M
CompanyStageDateRound SizeTotal Raised
Slate Medicines
Series AFeb 2026$130M
$130M
Co-investors: Cindy Xiong (Foresite Capital)
Imbria Pharmaceuticals
Series BNov 2025
Series BApr 2025$67M
$67M
Alchemab Therapeutics
Series ASep 2025$32M
Series AApr 2021$83M
$120M
Co-investors: Houman Ashrafian (SV Health Investors), Kate Bingham (SV Health Investors)
Pahr Therapeutics
SeedJul 2025$14M
$14M
Aktis Oncology
Series BSep 2024$180M
$330M
Co-investors: Jason Ruth (MRL Ventures Fund), Todd Foley (MPM Capital)
Superluminal Medicines
Series ASep 2024$120M
SeedAug 2023$33M
$150M
Co-investors: Dylan Morris (Insight Partners)
Navigator Medicines
Series AAug 2024$100M
$100M
Co-investors: Wouter Joustra (Forbion)
Climb Bio
Post Ipo EquityApr 2024$120M
Series BMay 2021$60M
Series AMar 2021$80M
$260M
Co-investors: Liam Ratcliffe (New Leaf Venture Partners), Ohad Hammer (Xtripe Angels)
Director Clinton Health Access Initiative, Inc.Present
Vice President H.I.G. CapitalPresent
Managing Director RA Capital ManagementPresent
Partner and Managing Director RA Capital ManagementPresent
President, Founder HotmailPresent
Princeton University Bachelor of Science in Engineering, Bachelors Mechanical Engineering
Massachusetts Institute of Technology Doctorates, Doctor of Philosophy Biomedical Engineering